Skip to main content
Premium Trial:

Request an Annual Quote

BioIVT Acquires Virtual Biobank Tissue Solutions

NEW YORK — BioIVT said on Monday that it has acquired UK-based virtual biobank Tissue Solutions.

BioIVT said that it intends to continue operating Tissue Solutions' facilities. Financial terms of the deal were not disclosed.

Tissue Solutions provides a range of specimens through a global supplier network including fresh, frozen, and formalin-fixed, paraffin-embedded control tissue and skin samples; disease state peripheral blood mononuclear cells and bone marrow mononuclear cells; and fresh and frozen blood and biofluids.

Westbury, New York-based BioIVT markets research models and services for drug discovery and development, specializing in control and disease-state biospecimens such as human and animal tissues, cell products, blood, and other biofluids.

"This acquisition will add 150 collection sites to BioIVT's network, giving us greater access to high-quality control and disease state biospecimens and increased global reach for prospective collections," BioIVT CEO Jeff Gatz said in a statement. "Furthermore, it will expand our skin product offerings for in vitro models."

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.